Candesartan, an Insurmountable Antagonist of Angiotensin II-mediated Contractile Effects in Isolated Vascular Preparations: Comparison with Irbesartan, Losartan and its Active Metabolite (EXP-3174)

By MORSING P.   BRANDT-ELIASSON U.   RENBERG L.   ABRAHAMSSON T.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 50-51

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the Angiotensin II Receptor Antagonist Irbesartan With Atenolol for Treatment of Hypertension

By STUMPE K. O.   HAWORTH D.   HÖGLUND C.   KERWIN L.   MARTIN A.   SIMON T.   MASSON C.   KASSLER-TAUB K.   OSBAKKEN M.  

Blood Pressure, Vol. 7, Iss. 1, 1998-04 ,pp. : 31-37

Informa Healthcare

Access to resources Recommend Favorite

The Antihypertensive Effect and Tolerability of Candesartan Cilexetil, a New Generation Angiotensin II Antagonist, in Comparison with Losartan

By ANDERSSON OVE K.   NELDAM STEEN  

Blood Pressure, Vol. 7, Iss. 1, 1998-04 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

Effects of Selective Angiotensin II Type 1 Receptor Blockade with Losartan on Arterial Compliance in Patients with Mild Essential Hypertension

By KLEMSDAL TOR O.   MOAN ANDREAS   KJELDSEN SVERRE E.  

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 214-219

Informa Healthcare

Access to resources Recommend Favorite

Effects of angiotensin II receptor blockade‐based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients

By Cuspidi Cesare   Meani Stefano   Valerio Cristiana   Fusi Veronica   Sala Carla   Maisaidi Meilikemu   Zanchetti Alberto  

Blood Pressure, Vol. 15, Iss. 2, 2006-04 ,pp. : 107-115

Informa Healthcare

Access to resources Recommend Favorite